Azor and Ampyra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azor (amlodipine besylate; olmesartan medoxomil) and Ampyra (dalfampridine). Common drug interactions include gait disturbance among females and gait disturbance among males.

The phase IV clinical study analyzes what interactions people have when they take Azor and Ampyra. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.

What is Azor?

Azor has active ingredients of amlodipine besylate; olmesartan medoxomil. It is often used in high blood pressure. eHealthMe is studying from 3,922 Azor users. Check the latest studies of Azor.

What is Ampyra?

Ampyra has active ingredients of dalfampridine. It is often used in multiple sclerosis. eHealthMe is studying from 77,145 Ampyra users. Check the latest studies of Ampyra.

On Jul, 14, 2026

29 people who take Azor and Ampyra together, and have interactions are studied.

What are the common drug interactions of Azor and Ampyra, by gender? *:

female:

Gait disturbance
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Abdominal discomfort
Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
Burning sensation
Lymphoedema (localized fluid retention and tissue swelling)
Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Spinal disorder (disease of spine a back bone)
Spinal pain (pain in spine)

male:

Gait disturbance

What are the common drug interactions of Azor and Ampyra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Gait disturbance
Fall
Hospitalisation
Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
Back pain
Pain
Agitation (state of anxiety or nervous excitement)
Agraphia (a loss of the ability to write or to express thoughts in writing because of a brain lesion)
Anxiety
Arthralgia (joint pain)

60+:

Gait disturbance
Abdominal discomfort
Confusional state
Contusion (a type of hematoma of tissue in which capillaries)
Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
Depressed mood
Dry mouth
Dysstasia (difficulty in standing)
Fall
Fear

What are the existing conditions these people have? *

Gait Disturbance: 11 people, 37.93%
Spinal Pain (pain in spine): 3 people, 10.34%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 10.34%
Depression: 2 people, 6.90%

* Approximation only. Some reports may have incomplete information.

Do you take Azor and Ampyra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously